Vik Chopra
Stock Analyst at Wells Fargo
(1.70)
# 3,328
Out of 4,967 analysts
49
Total ratings
33.33%
Success rate
-7.01%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Maintains: Overweight | $17 → $15 | $9.14 | +64.11% | 3 | Aug 13, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $76 → $66 | $59.90 | +10.18% | 10 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Overweight | $48 → $41 | $30.84 | +32.94% | 4 | Aug 8, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $75 → $79 | $71.82 | +10.00% | 4 | Aug 8, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $16 → $15 | $13.81 | +8.62% | 3 | Aug 8, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $17 → $19 | $20.72 | -8.30% | 3 | Aug 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $246 → $199 | $137.16 | +45.09% | 3 | Jul 31, 2025 | |
| MASI Masimo | Maintains: Overweight | $205 → $190 | $137.67 | +38.01% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $15.17 | -14.28% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $68.39 | +9.67% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $57 | $53.55 | +6.44% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $15.68 | +21.17% | 1 | Aug 1, 2024 |
NeuroPace
Aug 13, 2025
Maintains: Overweight
Price Target: $17 → $15
Current: $9.14
Upside: +64.11%
Globus Medical
Aug 8, 2025
Maintains: Overweight
Price Target: $76 → $66
Current: $59.90
Upside: +10.18%
Enovis
Aug 8, 2025
Maintains: Overweight
Price Target: $48 → $41
Current: $30.84
Upside: +32.94%
Solventum
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $75 → $79
Current: $71.82
Upside: +10.00%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $13.81
Upside: +8.62%
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $17 → $19
Current: $20.72
Upside: -8.30%
Align Technology
Jul 31, 2025
Maintains: Overweight
Price Target: $246 → $199
Current: $137.16
Upside: +45.09%
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $137.67
Upside: +38.01%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $15.17
Upside: -14.28%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $68.39
Upside: +9.67%
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $53.55
Upside: +6.44%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $15.68
Upside: +21.17%